Literature DB >> 11372739

Long-term engraftment stability of peripheral blood stem cells cryopreserved using the dump-freezing method in a -80 degrees C mechanical freezer with 10% dimethyl sulfoxide.

C W Choi1, B S Kim, J H Seo, S W Shin, Y H Kim, J S Kim.   

Abstract

In this study, we summarize our long-term follow-up data of 24 patients who underwent autologous peripheral blood stem cell transplantation (PBSCT) using the dump-freezing method in a -80 degrees C freezer. Collected peripheral blood mononuclear cells were mixed with a cryoprotectant solution consisting of autologous plasma and 20% dimethyl sulfoxide, then placed in a -80 degrees C freezer. The recovery rate of mononuclear cells (MNCs), colony-forming unit-granulocyte/macrophage (CFU-GM) colonies, and CD34+ cells were calculated. Engraftment time (with neutrophil count > 0.5 x 10(9)/L, platelet count > 50 x 10(9)/L) and normal hemopoiesis (neutrophil count > 2 x 10(9)/L, platelet count > 100 x 10(9)/L) were evaluated. Median duration of cryopreservation was 76 days. The mean recovery rates of MNCs, CFU-GM colonies, and CD34+ cells were 93.4%, 78.4%, and 95.3%, respectively. The median engraftment times of neutrophils and platelets were 8 and 27 days, respectively. The median normal hemopoiesis times of neutrophil and platelet were 31 and 45 days, respectively. Nine patients are alive and in complete remission (CR). Seven patients in first CR sustained normal hemopoiesis with a median duration of 35 months. Two patients, who achieved second CR after salvage chemotherapy due to a leukemia relapse after PBSCT, maintained engraftment status for 24 and 28 months, and 1 reached normal hemopoiesis. These results demonstrate that PBSCT using the dump-freezing method in a -80 degrees C freezer leads to acceptable long-term engraftment stability.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11372739     DOI: 10.1007/bf02981945

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  12 in total

1.  Simplification of the blood stem cell transplantation (BSCT) procedure: large volume apheresis and uncontrolled rate cryopreservation at -80 degrees C.

Authors:  W W Feremans; G Bastin; F L Moine; C Ravoet; J P Delville; O Pradier; G Wallef; E Dupont; P Capel; M Lambermont
Journal:  Eur J Haematol       Date:  1996-05       Impact factor: 2.997

2.  A simplified method for cryopreservation of peripheral blood stem cells at -80 degrees C without rate-controlled freezing.

Authors:  S Makino; M Harada; K Akashi; S Taniguchi; T Shibuya; S Inaba; Y Niho
Journal:  Bone Marrow Transplant       Date:  1991-10       Impact factor: 5.483

3.  Hematopoietic cell transplantation using plasma and DMSO without HES, with non-programmed freezing by immersion in a methanol bath: results in 213 cases.

Authors:  F Hernández-Navarro; E Ojeda; R Arrieta; P Ríos-Rull; J García-Bustos; E Quevedo; M P Martín Hernández; V Jiménez-Yuste; M Rodríguez-Luaces; R M López; P García-Miguel; A Martínez; A Sastre; F Calero; F Gómez-Pastrana; B Martínez
Journal:  Bone Marrow Transplant       Date:  1998-03       Impact factor: 5.483

4.  Autologous bone marrow transplantation using unfractionated cells cryopreserved in dimethylsulfoxide and hydroxyethyl starch without controlled-rate freezing.

Authors:  P J Stiff; A R Koester; M K Weidner; K Dvorak; R I Fisher
Journal:  Blood       Date:  1987-10       Impact factor: 22.113

5.  Engraftment kinetics and long-term stability of hematopoiesis following autografting of peripheral blood stem cells.

Authors:  A Indovina; I Majolino; F Buscemi; R Scimè; S Vasta; A Santoro; M Pampinella; P Catania; F Caronia
Journal:  Haematologica       Date:  1995 Mar-Apr       Impact factor: 9.941

6.  Effect of CD34(+) cell dose on resource utilization in patients after high-dose chemotherapy with peripheral-blood stem-cell support.

Authors:  K A Schulman; R Birch; B Zhen; N Pania; C H Weaver
Journal:  J Clin Oncol       Date:  1999-04       Impact factor: 44.544

7.  Mitoxantrone, etoposide, and intermediate-dose cytarabine: an effective and tolerable regimen for the treatment of refractory acute myeloid leukemia.

Authors:  S Amadori; W Arcese; G Isacchi; G Meloni; M C Petti; B Monarca; A M Testi; F Mandelli
Journal:  J Clin Oncol       Date:  1991-07       Impact factor: 44.544

8.  Mitoxantrone, etoposide and intermediate-dose Ara-C (MEC): an effective regimen for poor risk acute myeloid leukemia.

Authors:  A Spadea; M C Petti; P Fazi; M L Vegna; W Arcese; G Avvisati; M A Aloe Spiriti; R Latagliata; G Meloni; A M Testi
Journal:  Leukemia       Date:  1993-04       Impact factor: 11.528

9.  Long-term storage at -80 degrees C of hematopoietic progenitor cells with 5-percent dimethyl sulfoxide as the sole cryoprotectant.

Authors:  A Galmés; J Besalduch; J Bargay; A Novo; M Morey; J M Guerra; M A Duran
Journal:  Transfusion       Date:  1999-01       Impact factor: 3.157

10.  A simplified method for cryopreservation of hematopoietic stem cells with -80 degrees C mechanical freezer with dimethyl sulfoxide as the sole cryoprotectant.

Authors:  A Galmés; J Besalduch; J Bargay; N Matamoros; M Morey; A Novo; A Sampol
Journal:  Leuk Lymphoma       Date:  1995-03
View more
  7 in total

1.  Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art.

Authors:  Arianna Malgieri; Eugenia Kantzari; Maria Patrizia Patrizi; Stefano Gambardella
Journal:  Int J Clin Exp Med       Date:  2010-09-07

2.  Cryopreservation of Human Stem Cells for Clinical Application: A Review.

Authors:  Charles J Hunt
Journal:  Transfus Med Hemother       Date:  2011-03-16       Impact factor: 3.747

3.  Impact of uncontrolled freezing and long-term storage of peripheral blood stem cells at - 80 °C on haematopoietic recovery after autologous transplantation. Report from two centres.

Authors:  G Detry; L Calvet; N Straetmans; A Cabrespine; C Ravoet; J O Bay; H Petre; C Paillard; B Husson; E Merlin; L Boon-Falleur; O Tournilhac; A Delannoy; P Halle
Journal:  Bone Marrow Transplant       Date:  2014-03-31       Impact factor: 5.483

4.  Cryopreserved Mesenchymal Stromal Cells Are Susceptible to T-Cell Mediated Apoptosis Which Is Partly Rescued by IFNγ Licensing.

Authors:  Raghavan Chinnadurai; Ian B Copland; Marco A Garcia; Christopher T Petersen; Christopher N Lewis; Edmund K Waller; Allan D Kirk; Jacques Galipeau
Journal:  Stem Cells       Date:  2016-07-04       Impact factor: 6.277

5.  Outcome of 51 autologous peripheral blood stem cell transplants after uncontrolled-rate freezing ("dump freezing") using -80°C mechanical freezer.

Authors:  Rasika Dhawan Setia; Satyam Arora; Anil Handoo; Dharma Choudhary; Sanjeev Kumar Sharma; Vipin Khandelwal; Meenu Kapoor; Shalu Bajaj; Tina Dadu; Gaurav Dhamija; Virendra Bachchas
Journal:  Asian J Transfus Sci       Date:  2018 Jul-Dec

6.  Freeze-drying of mononuclear cells derived from umbilical cord blood followed by colony formation.

Authors:  Dity Natan; Arnon Nagler; Amir Arav
Journal:  PLoS One       Date:  2009-04-21       Impact factor: 3.240

7.  Lyophilized platelet-rich fibrin (PRF) promotes craniofacial bone regeneration through Runx2.

Authors:  Qi Li; David A Reed; Liu Min; Gokul Gopinathan; Steve Li; Smit J Dangaria; Leo Li; Yajun Geng; Maria-Therese Galang; Praveen Gajendrareddy; Yanmin Zhou; Xianghong Luan; Thomas G H Diekwisch
Journal:  Int J Mol Sci       Date:  2014-05-14       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.